Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Begum

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Infection and Immunity|February 24, 2010
Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in BangladeshFahima Chowdhury, Yasmin A Begum, Mohammad Murshid Alam, et al.
Nature Genetics|June 27, 2018
Defining endemic cholera at three levels of spatiotemporal resolution within BangladeshDaryl Domman, Fahima Chowdhury, Ashraful I Khan, et al.
JCO Oncology Advances|February 25, 2026
Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk FeaturesThikhamporn Tawantanakorn, A Begum Bektas, Matthew Hill, et al.
The Journal of Infectious Diseases|April 17, 2018
Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae InfectionFiras S Midani, Ana A Weil, Fahima Chowdhury, et al.
Science (New York, N.Y.)|April 26, 2024
Phage predation, disease severity, and pathogen genetic diversity in cholera patientsNaïma Madi, Emilee T Cato, Md Abu Sayeed, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Phage predation, disease severity and pathogen genetic diversity in cholera patientsNaïma Madi, Emilee T Cato, Md Abu Sayeed, et al.
Oncogene|June 6, 2017
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3S Sengupta, A Nagalingam, N Muniraj, et al.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
The Science of the Total Environment|August 1, 2008
Urban air quality in the Asian regionPhilip K Hopke, David D Cohen, Bilkis A Begum, et al.
The Lancet. Digital Health|December 17, 2020
Electronic decision support and diarrhoeal disease guideline adherence (mHDM): a cluster randomised controlled trialAshraful I Khan, Jasmine A Mack, M Salimuzzaman, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Infection and Immunity|February 24, 2010
Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in BangladeshFahima Chowdhury, Yasmin A Begum, Mohammad Murshid Alam, et al.
Nature Genetics|June 27, 2018
Defining endemic cholera at three levels of spatiotemporal resolution within BangladeshDaryl Domman, Fahima Chowdhury, Ashraful I Khan, et al.
JCO Oncology Advances|February 25, 2026
Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk FeaturesThikhamporn Tawantanakorn, A Begum Bektas, Matthew Hill, et al.
The Journal of Infectious Diseases|April 17, 2018
Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae InfectionFiras S Midani, Ana A Weil, Fahima Chowdhury, et al.
Science (New York, N.Y.)|April 26, 2024
Phage predation, disease severity, and pathogen genetic diversity in cholera patientsNaïma Madi, Emilee T Cato, Md Abu Sayeed, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Phage predation, disease severity and pathogen genetic diversity in cholera patientsNaïma Madi, Emilee T Cato, Md Abu Sayeed, et al.
Oncogene|June 6, 2017
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3S Sengupta, A Nagalingam, N Muniraj, et al.
Vaccine|November 27, 2018
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analysesMarjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, et al.
The Science of the Total Environment|August 1, 2008
Urban air quality in the Asian regionPhilip K Hopke, David D Cohen, Bilkis A Begum, et al.
The Lancet. Digital Health|December 17, 2020
Electronic decision support and diarrhoeal disease guideline adherence (mHDM): a cluster randomised controlled trialAshraful I Khan, Jasmine A Mack, M Salimuzzaman, et al.
Pageof 36